Latest news from Neobiomics
- News
The first activity launches today, on World Sight Day: a new section on retinopathy of prematurity (ROP) on Neopedia, GFCNI’s global information platform for parents, which aims to raise awareness of ROP among families worldwide. Stockholm, Sweden – 8 October 2026. ROP is an eye condition that can develop when
- Insights
Preterm birth occurs during a period of rapid gastrointestinal and immune development. At the same time, microbial colonisation begins under conditions that differ considerably from those experienced by term-born infants. During the first weeks of life, the gut microbiota of preterm infants is typically less diverse and more variable between
- Conference, Insights
ESPGHAN 2026: revisiting the key scientific highlights ESPGHAN 2026 once again brought together the neonatal community to exchange knowledge, discuss emerging evidence and explore the latest advances in neonatal nutrition. To help healthcare professionals revisit the meeting, we’ve created a dedicated resource bringing together the key scientific highlights from selected
- News
HealthCap invests in Neobiomics to support continued growth in neonatal care Stockholm, Sweden – 20 May 2026. Neobiomics AB, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, today announced an investment led by HealthCap, one of Europe’s leading life science venture capital
- NeoMega36, News
Exciting News! We’re pleased to share that NeoMega36 has now been notified in Spain — an important step forward in making this innovation more widely available to clinicians and preterm infants across Europe.NeoMega36 is specifically developed to support the development of normal visual function in preterm infants, contributing to healthier starts and brighter futures for